Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
2(50.0%)
4Total
Phase 4(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06829979Not ApplicableCompleted

Improving Night Shift Nurses' Health and Reducing Burnout

Role: collaborator

NCT05263635Not ApplicableCompleted

Music Therapy in the Treatment of Perioperative Anxiety and Pain

Role: collaborator

NCT00177970Phase 4Terminated

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

Role: collaborator

NCT00177866Phase 4Terminated

Safety of Celecoxib in Patients With Crohn's Disease

Role: collaborator

All 4 trials loaded